Skip to search formSkip to main contentSkip to account menu

N,N-dimethyldoxorubicin

Known as: 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(dimethylamino)-alpha-L-lyxo-hexopyranosyl)oxy)-, (8S-cis)-, N,N-dimethyladriamycin 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Doxorubicin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Decreased resistance toN,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells
SummaryDoxorubicin-resistant Friend erythroleukemia cells, line F4–6 ADM2R, were selected by exposure of wild-type F4-6 cells to… 
1993
1993
Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells.
Doxorubicin-resistant Friend erythroleukemia cells, line F4-6 ADM2R, were selected by exposure of wild-type F4-6 cells to… 
1991
1991
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial.
One hundred seventy-nine patients with intermediate or high-grade non-Hodgkin's lymphoma were randomized to receive either… 
1991
1991
Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
The effect of adriamycin, daunomycin, N,N-dimethyladriamycin, N,N-dimethyldaunomycin, pyrromycin, marcellomycin, and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)